{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:56:26Z","timestamp":1789588586465,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.09.006","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T07:18:10Z","timestamp":1253085490000},"page":"6905-6909","source":"Crossref","is-referenced-by-count":18,"title":["Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB\/c mice"],"prefix":"10.1016","volume":"27","author":[{"given":"Shailendra Kumar","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Vedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailja Misra","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.V.","family":"Lakshmana Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.09.006_bib1","series-title":"The togaviruses","first-page":"47","article-title":"Medical significance of togaviruses: an overview of diseases caused by togaviruses in man and in domestic and wild vertebrate animals","author":"Shope","year":"1980"},{"key":"10.1016\/j.vaccine.2009.09.006_bib2","series-title":"The Togaviridae and Flaviviridae","first-page":"375","article-title":"Pathobiology of the flaviviruses","author":"Monath","year":"1986"},{"key":"10.1016\/j.vaccine.2009.09.006_bib3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4269\/ajtmh.1959.8.698","article-title":"Ecologic studies of Japanese encephalitis virus in Japan: VI. swine infection","volume":"8","author":"Scherer","year":"1959","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.006_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/oxfordjournals.aje.a120643","article-title":"Cyclic outbreaks of Japanese encephalitis among pigs and humans","volume":"84","author":"Konno","year":"1966","journal-title":"Am J Epidemiol"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2009.09.006_bib5","first-page":"26","article-title":"The role of mammals as primary and supplementary hosts","volume":"20","author":"Oya","year":"1967","journal-title":"Jpn J Med Sci Biol"},{"issue":"44","key":"10.1016\/j.vaccine.2009.09.006_bib6","first-page":"337","article-title":"Japanese encephalitis vaccines","volume":"73","year":"1998","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2009.09.006_bib7","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines","volume":"319","author":"Hoke","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.09.006_bib8","first-page":"95","article-title":"Field experiments on live attenuated Japanese encephalitis virus vaccine for swine","volume":"21","author":"Ueba","year":"1978","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2009.09.006_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1988.39.214","article-title":"Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children","volume":"39","author":"Xin","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2009.09.006_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jmv.1890440204","article-title":"Homologous and heterologous neutralization antibody responses after immunization with Japanese encephalitis vaccine among Taiwan children","volume":"44","author":"Ku","year":"1994","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2009.09.006_bib11","first-page":"961","volume":"vol. 1","author":"Monath","year":"1996"},{"key":"10.1016\/j.vaccine.2009.09.006_bib12","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1086\/517323","article-title":"Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26, 239 subjects","volume":"176","author":"Liu","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.006_bib13","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0140-6736(96)91075-2","article-title":"Effectiveness of live attenuated Japanese encephalitis vaccine (SA14-14-2): a case\u2013control study","volume":"347","author":"Hennessy","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.09.006_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0163-4453(96)91281-5","article-title":"Adverse reactions to Japanese encephalitis vaccine in travellers","volume":"32","author":"Nothdurft","year":"1996","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2009.09.006_bib15","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/infdis\/161.5.878","article-title":"Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants","volume":"161","author":"Poland","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.006_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0264-410X(96)00170-3","article-title":"Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines","volume":"15","author":"Sakaguchi","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.006_bib17","first-page":"25","article-title":"Neutralizing antibody responses to Japanese encephalitis vaccine in children","volume":"26","author":"Juang","year":"1983","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2009.09.006_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/viro.1999.9859","article-title":"prediction of three-dimensional structure and mapping of conformational epitopes of envelope glycoprotein of Japanese encephalitis virus","volume":"261","author":"Kolaskar","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.09.006_bib19","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1128\/JVI.77.4.2600-2606.2003","article-title":"A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining site","volume":"77","author":"Lin","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.09.006_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2\u00c5 resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.09.006_bib21","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","article-title":"Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells","volume":"75","author":"Crill","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.09.006_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0042-6822(91)90471-M","article-title":"Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants","volume":"181","author":"Cecilia","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.09.006_bib23","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/0264-410X(95)00097-K","article-title":"Finer mapping of neutralizing epitope(s) on the C-terminal of Japanese encephalitis virus E-protein expressed in recombinant Escherichia coli system","volume":"13","author":"Seif","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.006_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0168-1702(97)00098-1","article-title":"Japanese encephalitis virus antigenic variants with characteristics differences in neutralization resistance and mouse virulence","volume":"51","author":"Wu","year":"1997","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2009.09.006_bib25","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.2174\/092986609789353709","article-title":"Antibodies against refolded recombinant envelope protein (domain III) of Japanese encephalitis virus inhibit the JEV infection to porcine stable kidney cells","volume":"16","author":"Verma","year":"2009","journal-title":"Protein Peptide Lett"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.006_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1365-3156.1998.00161.x","article-title":"Cellular response of Mastomys and gerbil in experimental filariasis","volume":"3","author":"Misra","year":"1998","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2009.09.006_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-1759(89)90198-1","article-title":"Specific assays for cytokine production by T-cells","volume":"116","author":"Mosmann","year":"1989","journal-title":"J Immunol Methods"},{"issue":"pt8","key":"10.1016\/j.vaccine.2009.09.006_bib28","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1099\/0022-1317-70-8-2037","article-title":"Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein","volume":"70","author":"Mason","year":"1989","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.09.006_bib29","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/S0264-410X(03)00042-2","article-title":"The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuventicity","volume":"21","author":"Wu","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.006_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00430-007-0043-4","article-title":"Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice","volume":"196","author":"Alka","year":"2007","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2009.09.006_bib31","series-title":"Immunology","author":"Roitt","year":"2001"},{"key":"10.1016\/j.vaccine.2009.09.006_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/viro.1999.9738","article-title":"Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways","volume":"2","author":"Zhou","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.09.006_bib33","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1126\/science.8456301","article-title":"Immune response in mice that lack the interferon-gamma receptor","volume":"5102","author":"Huang","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2009.09.006_bib34","doi-asserted-by":"crossref","first-page":"9580","DOI":"10.1128\/JVI.74.20.9580-9585.2000","article-title":"The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus","volume":"20","author":"Stojdl","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.09.006_bib35","first-page":"469","article-title":"Effect of IL-6 and TNF-alpha on Dengue virus infection of human dendritic cells","volume":"4","author":"Shi","year":"2006","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"10.1016\/j.vaccine.2009.09.006_bib36","series-title":"Principles of virology, molecular biology, pathogenesis, and control of animal viruses","author":"Flint","year":"2000"},{"key":"10.1016\/j.vaccine.2009.09.006_bib37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2009.09.006_bib38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0091-6749(96)80146-1","article-title":"Update on cytokines","volume":"3","author":"Borish","year":"1996","journal-title":"J Allergy Clin Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T12:33:40Z","timestamp":1558528420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09013309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":38,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0264410X09013309"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}